نتایج جستجو برای: 15.6 and 15.5
تعداد نتایج: 16831116 فیلتر نتایج به سال:
CONTENTS Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 154 Definitions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 154 Patient considerations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...
CONTENTS Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 154 Definitions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 154 Patient considerations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...
............................................................................................................................................... 141 Literatur................................................................................................................................................ 146 A Softwaretechnische Basis ...................................................................
Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.
INTRODUCTION .......................................................................................................................................................149 TAXONOMY ...............................................................................................................................................................149 Historical Features ........................................
ZfP Zeitschrift für Politik , Seite 155 - 156
CONXENTS LIFE CYCLES ......................................................... 151 RECOMBINATION ....................................................... 152 Tetrad and random spore analysis; procedures ............................ 152 Chromosome maps ................................................... 153 Interference, chiasma, and chromatid .................................... 153 Gene convers...
C O N T E N T S 1. In t roduc t ion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 154 1.1. M o r p h o l o g y of Ret inal Glial Cells . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 154 1.1.1. Miil ler cells . . . . . . . . . . . . . . . . . . . ...
Protein Therapeutics versus Small Molecule Drugs .............................................. 154 Sources of Protein Therapeutics ................................................................... 155 Targets of Protein Therapeutics and Modes of Action .................................. 155 Engineering Effective Protein Therapeutics .......................................................... ...
Explanation.................................................................................................. 149 Evaluation for acceptable daily intake......................................................... 150 Biochemical aspects........................................................................... 150 Absorption, distribution and excretion ....................................... 150 B...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید